In this issue, we look at the BIOSECURE Act, and how it fails to address chokepoints and dangerous dependencies in the supply of vital drugs. We also look at the DOJ’s transformative victory in the Google search case.

An April article written by Open Markets fellow Garphil Julien contrasting President Biden’s approach to trade with his predecessor’s, which noted that while the trade deficit dipped under Trump, it contracted by the largest amount in 14 years in 2023 under Biden.

In this issue, we take a look at how the Department of Transportation could exercise its authority to reign in the airlines as travelers suffer unprecedented travel delays and cancellations this summer.

In this issue, we discuss a major supply chain chokepoint that may pose an obstacle to increasing supply in the oil industry, Regeneron Pharmaceutical’s lawsuit against Novartis Pharma alleging monopolization and restraint of trade, and supply chain problems in the fertilizer industry.

In this issue, we discuss the legislative solutions to fix the semiconductor chip shortage, our Executive Director Barry Lynn’s testimony in the House on monopolists’ role in driving up inflation, and a newly launched European Grassroots Antimonopoly Group.

In this issue, we take a closer look at how the transition to renewable energy will be hampered if the U.S. continues its overreliance on minerals concentrated in nations considered to be foreign adversaries.